JAKARTA, Oct 9 (Xinhua): Indonesia's drug and food authority BPOM has announced that it has issued an emergency use authorization (EUA) for the Zifivax Covid-19 vaccine produced by Chinese biopharmaceutical company Anhui Zhifei Longcom.
"Today, BPOM again announces that we have approved a Covid-19 vaccine product under the trade name Zifivax which was developed with a recombinant protein sub-unit platform," BPOM's head Penny Lukito told a virtual press conference.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!